CCEL Logo

Cryo-Cell International, Inc. (CCEL) Insider Trading Activity

NASDAQ$4.95+0.09 (1.85%)
Market Cap
$39.28M
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
487 of 877
Rank in Industry
24 of 40

Largest Insider Buys in Sector

$337M
$259M
$79M
$76M
$60M
$57M

CCEL Insider Trading Activity

CCEL Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Cryo-Cell International, Inc.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Insider Activity of Cryo-Cell International, Inc.

Over the last 12 months, insiders at Cryo-Cell International, Inc. have bought $0 and sold $0 worth of Cryo-Cell International, Inc. stock.

On average, over the past 5 years, insiders at Cryo-Cell International, Inc. have bought $683,027 and sold $338,155 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 534 shares for transaction amount of $2,617 was made by PORTNOY DAVID (Chairman, Co‑CEO) on 2022‑11‑18.

List of Insider Buy and Sell Transactions, Cryo-Cell International, Inc.

2022-11-18PurchasePORTNOY DAVIDChairman, Co-CEO
534
0.0063%
$4.90
$2,617
-3.47%
2022-11-17PurchasePORTNOY DAVIDChairman, Co-CEO
516
0.0061%
$4.90
$2,528
-3.47%
2022-11-15SalePORTNOY DAVIDChairman, Co-CEO
16,000
0.1842%
$4.80
$76,860
-3.45%
2022-11-15PurchasePORTNOY DAVIDChairman, Co-CEO
9,491
0.1092%
$4.80
$45,557
-3.45%
2022-11-14SalePORTNOY DAVIDChairman, Co-CEO
10,000
0.1152%
$4.80
$48,000
-2.59%
2022-11-14PurchasePORTNOY DAVIDChairman, Co-CEO
10,000
0.1152%
$4.80
$48,000
-2.59%
2022-11-11SalePORTNOY DAVIDChairman, Co-CEO
9,495
0.1126%
$4.79
$45,471
+0.11%
2022-11-11PurchasePORTNOY DAVIDChairman, Co-CEO
6,000
0.0711%
$4.79
$28,710
+0.11%
2022-11-10SalePORTNOY DAVIDChairman, Co-CEO
5,505
0.0645%
$4.91
$27,015
-3.65%
2022-11-10PurchasePORTNOY DAVIDChairman, Co-CEO
3,850
0.045%
$4.90
$18,865
-3.65%
2022-11-08SalePORTNOY DAVIDChairman, Co-CEO
15,000
0.1866%
$5.02
$75,350
-0.11%
2022-11-08PurchasePORTNOY DAVIDChairman, Co-CEO
20,000
0.2424%
$4.89
$97,900
-0.11%
2021-09-01SaleGaines Georgedirector
3,699
0.0416%
$11.70
$43,278
-31.99%
2021-08-31SaleGaines Georgedirector
2,330
0.0276%
$11.61
$27,057
-26.30%
2021-08-30SaleGaines Georgedirector
10,000
0.1355%
$11.48
$114,800
-24.20%
2021-07-23PurchasePORTNOY DAVIDChairman, Co-CEO
158
0.0021%
$9.45
$1,493
-2.05%
2021-07-19PurchasePORTNOY DAVIDChairman, Co-CEO
100
0.0013%
$9.23
$924
+0.92%
2021-05-27PurchasePORTNOY DAVIDChairman, Co-CEO
946
0.0134%
$8.65
$8,183
+9.80%
2021-05-21PurchasePORTNOY DAVIDChairman, Co-CEO
1,000
0.0142%
$8.46
$8,460
+12.80%
2021-05-13PurchasePORTNOY DAVIDChairman, Co-CEO
2,000
0.0284%
$8.55
$17,100
+11.05%
Total: 279

Insider Historical Profitability

44.63%
Choi Ki Yong
2144929
26.5391%
$10.42M90
+12.6%
Nyberg Mary J10 percent owner
700000
8.6611%
$3.4M01
SHEEHY BRIAN L.director
496503
6.1432%
$2.41M60
Portnoy Mark L.Co-Chief Executive Officer
487514
6.032%
$2.37M216
PORTNOY DAVIDChairman, Co-CEO
230621
2.8535%
$1.12M14818
<0.0001%
Wheeler Jonathan H.director
76600
0.9478%
$372,276.0040
Ellis Arthurdirector
30078
0.3722%
$146,179.0850
Berger Harold D.director
27801
0.344%
$135,112.8620
SHETH JAGDISH Ndirector
20000
0.2475%
$97,200.0020
+266.83%
MAASS GERALD FExec Vice President
16000
0.198%
$77,760.0003
GOUBRAN GABY Wdirector
11255
0.1393%
$54,699.3001
DEUTSCH E THOMAS IIIVP Technology, CIO
9705
0.1201%
$47,166.3001
CHRISTIAN SCOTT Gdirector
6776
0.0838%
$32,931.3601
Gaines Georgedirector
0
0%
$03812
Mikulinsky OlegChief Information Officer
0
0%
$001

CCEL Institutional Investors: Active Positions

Increased Positions11+91.67%116,849+12.76%
Decreased Positions2-16.67%14,691-1.6%
New Positions5New95,067New
Sold Out Positions<1Sold Out14,433Sold Out
Total Postitions21+75%1M+11.15%

CCEL Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Hamilton Lane Advisors Llc$1,987.005.12%409,73400%2025-03-31
Sfi Advisors, Llc$802.002.07%165,30000%2024-12-31
Vanguard Group Inc$567.001.46%116,956+108+0.09%2024-12-31
Massmutual Private Wealth & Trust, Fsb$539.001.39%111,03500%2025-03-31
Topline Capital Management, Llc$232.000.6%47,791+47,791New2024-12-31
Geode Capital Management, Llc$193.000.5%39,86000%2024-12-31
Northern Trust Corp$189.000.49%38,902+17,066+78.16%2024-12-31
Heron Bay Capital Management$154.000.4%31,766+31,766New2024-12-31
Cerity Partners Llc$95.000.25%19,56300%2025-03-31
Creativeone Wealth, Llc$74.000.19%15,310+15,310New2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.